Last updated: April 25, 2026
Who Supplies MARCAINE (Bupivacaine)?
MARCAINE is a brand name for bupivacaine, a local anesthetic produced and distributed by AbbVie (formerly Allergan) in multiple formulations and strengths (e.g., injection and related local anesthesia presentations). The supplier landscape is organized around (1) the branded-marketed product owner, (2) contract manufacturers that fill and finish the drug product, and (3) raw-material supply for the active pharmaceutical ingredient (API) and excipients.
What companies supply MARCAINE to the market?
Brand owner and primary marketer
- AbbVie (Allergan legacy): Markets MARCAINE (bupivacaine) in the US and in other markets where the brand is maintained, including various bupivacaine hydrochloride injection strengths and indications. (Source: AbbVie product materials for MARCAINE.)
Manufacturers that can appear as responsible suppliers on regulatory filings
The drug supply chain for MARCAINE typically involves:
- API manufacturers supplying bupivacaine hydrochloride to a finished-dose manufacturer, and
- Drug product manufacturers (fill-finish and formulation) listed on regulatory submissions.
However, without the specific MARCAINE presentation (strength, dosage form, and NDC) and without access to the relevant regulatory dossier for each presentation, the exact contract manufacturer identities cannot be stated accurately in a way that would support transaction-level decisions.
What does “supplier” mean for MARCAINE in practice?
A pharmaceutical “supplier” for a branded injectables product usually maps to one or more of the following roles:
| Supplier role |
Typical responsibility |
Where it shows up |
| Brand owner / marketer |
Holds the US brand strategy, labeling, and distribution agreements |
US label imprinting and product communications |
| Drug product manufacturer |
Manufactures, fills, and packages the injectable |
Registration listings, regulatory submissions |
| API manufacturer |
Manufactures bupivacaine starting material at API stage |
API listing in regulatory dossiers or DMF-linked references |
| Excipients suppliers |
Provides solvents, buffers, stabilizers, and container-grade components |
Vendor qualification files, excipient references in dossiers |
For MARCAINE, the only supplier identity that can be stated cleanly from the information available here is the brand owner/marketer (AbbVie). The rest of the chain requires presentation-specific regulatory documents to name the correct manufacturing sites and API suppliers.
Key points to use for sourcing decisions
- If the goal is direct market availability (buying the product), the relevant commercial supplier is the marketer/distributor network tied to AbbVie’s MARCAINE product line.
- If the goal is manufacturing capability benchmarking (identifying fill-finish or API alternatives), you must map the exact MARCAINE presentation to its regulatory manufacturing listings (site and responsibilities) and then identify the linked API and excipient references.
- If the goal is competitive biosupply and cost-of-goods analysis, the most actionable step is isolating the exact NDC/strength/container configuration, because supply chain identities can change by presentation even within the same brand.
What to extract from the MARCAINE label to lock down the correct supplier chain
The label and packaging typically provide:
- Product imprinting and manufacturer/distributor name(s)
- Presentation-specific strength and packaging format
- Marketing/distribution address blocks
That information is the anchor for matching the product to the correct regulatory manufacturing chain.
Key Takeaways
- AbbVie is the primary brand marketer for MARCAINE (bupivacaine).
- Naming specific contract manufacturers and API suppliers requires presentation-level regulatory mapping (strength, dosage form, and NDC) because supplier identities vary by product configuration.
- For sourcing and manufacturing due diligence, the supplier definition must be tied to the role: marketer vs drug product manufacturer vs API supplier.
FAQs
1) Who makes MARCAINE?
MARCAINE is marketed by AbbVie, as the brand owner for bupivacaine products.
2) Is MARCAINE a single supplier product?
No. MARCAINE supply typically spans multiple roles: brand marketing plus manufacturing and fill-finish, and upstream API/excipient supply.
3) Can generic bupivacaine be made by different suppliers?
Yes. Bupivacaine injection is a widely manufactured drug substance and product form, and supplier chains differ by manufacturer and presentation.
4) What information is needed to name the exact contract manufacturer sites?
Presentation-specific identifiers (strength, dosage form, and NDC) that allow mapping to regulatory manufacturing listings.
5) Who controls the commercial supply of MARCAINE?
AbbVie controls the brand and distribution framework for MARCAINE while manufacturing and packaging can be performed by contracted sites tied to each presentation.
References (APA)
[1] AbbVie. (n.d.). MARCAINE (bupivacaine) product information and prescribing resources. AbbVie.
